Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experience
Crossref DOI link: https://doi.org/10.1007/s10741-016-9583-2
Published Online: 2016-09-12
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Heggermont, Ward A. https://orcid.org/0000-0002-5368-2223
Goethals, Marc
Dierckx, Riet
Verstreken, Sofie
Bartunek, Jozef
Vanderheyden, Marc
Funding for this research was provided by:
Frans Van de Werf Fund for Clinical Cardiovascular Research
License valid from 2016-09-12